Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Activity-Dependent and Experience-Driven Myelination Provide New Directions for the Management of Multiple Sclerosis.
Synthesis of novel therapeutic agents for the treatment of multiple sclerosis: A brief overview.
Unique association of Waldenström macroglobulinemia with optic neuritis and monoclonal T cell expansion.
Long-term efficacy and safety of transanal irrigation in multiple sclerosis.
Epigenetics of Multiple Sclerosis: An Updated Review.
Acorda Therapeutics announces Hatch-Waxman extension of AMPYRA® (dalfampridine) sustained-release formulation patent
The effectiveness of dimethyl fumarate monotherapy in the treatment of relapsing-remitting multiple sclerosis: a systematic review and meta-analysis.
Thyroid autoimmunity and dysfunction in multiple sclerosis patients during long-term treatment with interferon beta or glatiramer acetate: an Italian multicenter study.
Genzyme’s once-daily, oral AUBAGIO® (teriflunomide) approved in Argentina for the treatment of relapsing multiple sclerosis
Teriflunomide attenuates immunopathological changes in the dark agouti rat model of experimental autoimmune encephalomyelitis.
The mediating role of processing speed in the relationship between depressive symptoms and cognitive function in multiple sclerosis.
Techniques and technologies for the bioanalysis of Sativex(®), metabolites and related compounds.
Phase IV, Rater-blinded, Randomized Study, Comparing the Effects of 250 mg of Betaseron With 20 mg of Copaxone in Patients With the Relapsing-remitting or Clinically Isolated Forms of Multiple Sclerosis Using 3 Tesla MRI With Triple-dose Gadolinium
Rituximab add-on therapy for breakthrough relapsing multiple sclerosis: a 52-week phase II trial.
JC polyomavirus mutants escape antibody-mediated neutralization.
Rituximab for relapsing-remitting multiple sclerosis.
The Effects of IFN-β 1a on the Expression of Inflammasomes and Apoptosis-Associated Speck-Like Proteins in Multiple Sclerosis Patients.
Every-other-day interferon beta-1b versus once-weekly interferon beta-1a for multiple sclerosis: results of a 2-year prospective randomised multicentre study (INCOMIN).
Gadolinium-based MRI characterization of leptomeningeal inflammation in multiple sclerosis.
Clinical efficacy of BG-12 (dimethyl fumarate) in patients with relapsing-remitting multiple sclerosis: subgroup analyses of the CONFIRM study.
Clinically isolated syndromes: a new oligoclonal band test accurately predicts conversion to MS.
Acute disseminated encephalomyelitis in 228 patients: A retrospective, multicenter US study.
Neuromyelitis optica spectrum disorder (NMOSD): A new concept.
Sleep and Cognitive Function in Multiple Sclerosis.
Vitamin D as an Early Predictor of Multiple Sclerosis Activity and Progression.

Pages